🇺🇸 LGND — Ligand Pharmaceuticals Incorporated

Salud Compra fuerte
← Volver

Precio actual

306,20 USD

Máx. histórico

322,75

7 días

Split 1603:1000 del 02/11/2022

Caída desde máximo

-5,13%

Rango 52 semanas

175,89 – 326,63

Variación hoy

+2,41%

Cierre anterior

299,00

Rango de hoy

297,84 – 308,26

Volumen hoy

130.173

Peor caída histórica

-93,34%

06/03/2000 → 19/11/2008

Recuperado en 2694 días

Volatilidad anualizada ⓘ

59,76%

Información
Nombre completo
Ligand Pharmaceuticals Incorporated
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
47
PER ⓘ
122,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
351,33 USD (puede no estar actualizado)
Primera cotización
18/11/1992
Precio actualizado
hace 21 horas
Sobre la empresa

Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.

Dividendos repartidos Total últimos 12 meses: 0,0000 USD · Yield: 0,00%
Fecha de pago Importe por participación
03/04/2007 9,3575 USD
Splits Registrados en el histórico de precios
Fecha Ratio
02/11/2022 1603:1000
19/11/2010 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/12/2005 41,47 41,62 41,17 41,62 +0,18% 1,08% 29.709
21/12/2005 40,99 41,62 40,42 41,55 +1,83% 2,92% 92.760
20/12/2005 40,46 41,02 40,35 40,80 +0,65% 1,67% 109.806
19/12/2005 40,99 41,02 40,05 40,54 -1,19% 2,37% 91.638
16/12/2005 41,85 41,92 40,42 41,02 -1,79% 3,58% 57.441
15/12/2005 41,55 42,30 41,36 41,77 +0,54% 2,25% 199.360
14/12/2005 42,26 42,30 39,30 41,55 -1,60% 7,09% 304.143
13/12/2005 42,03 43,04 42,03 42,22 +0,27% 2,40% 248.385
12/12/2005 43,61 44,02 42,11 42,11 -3,43% 4,38% 197.409
09/12/2005 41,55 43,79 39,60 43,61 +2,64% 10,09% 118.996
08/12/2005 41,55 43,04 41,55 42,48 +1,79% 3,60% 126.958
07/12/2005 41,66 41,92 41,55 41,73 +0,00% 0,90% 97.142
06/12/2005 41,55 41,92 41,55 41,73 +0,45% 0,90% 92.146
05/12/2005 41,17 42,41 41,17 41,55 +0,63% 3,00% 148.144
02/12/2005 42,11 43,04 40,99 41,29 -1,61% 4,89% 162.037
01/12/2005 41,47 42,11 41,17 41,96 +0,99% 2,26% 105.371
30/11/2005 41,29 42,00 40,42 41,55 +1,74% 3,81% 286.376
29/11/2005 40,09 41,17 40,05 40,84 +1,96% 2,80% 822.446
28/11/2005 38,74 40,20 38,25 40,05 +3,28% 5,02% 473.740
25/11/2005 38,67 39,30 37,62 38,78 -0,38% 4,36% 27.785
23/11/2005 37,62 39,86 37,36 38,93 +4,21% 6,67% 698.801
22/11/2005 36,83 37,43 36,53 37,36 +1,84% 2,44% 435.428
21/11/2005 36,12 36,87 35,37 36,68 +2,08% 4,15% 588.942
18/11/2005 38,63 38,78 35,75 35,93 -1,54% 7,85% 1.801.986
17/11/2005 33,99 36,49 33,99 36,49 +7,73% 7,38% 255.652
16/11/2005 32,94 34,44 32,19 33,87 +1,12% 6,82% 125.862
15/11/2005 35,37 35,56 32,68 33,50 -5,79% 8,15% 195.406
14/11/2005 33,87 36,87 33,87 35,56 +5,56% 8,84% 420.200
11/11/2005 30,58 33,87 30,54 33,69 +9,76% 10,89% 179.883
10/11/2005 30,43 30,69 30,32 30,69 +0,61% 1,23% 142.320